<DOC>
	<DOCNO>NCT01468636</DOCNO>
	<brief_summary>The purpose study examine effect 400 mg oral zinc gluconate genital wart . Our hypothesis 10 % difference complete clearance genital wart group randomize oral plus standard care compare randomize placebo plus standard care .</brief_summary>
	<brief_title>A RTC Examine Effectiveness 400 mg Oral Zinc Gluconate Adjunctive Therapy Ano-genital Warts</brief_title>
	<detailed_description>Clients present BCCDC STI clinic genital wart randomize either 400 mg zinc gluconate placebo ( 200mg BID ) 8 week addition standard care . Clinical assessment warts additional standard treatment occur every 7-10 day maximum 8 week . A telephone call occur week 20 determine wart clear re-appeared . The appearance new wart also note . The proportion subject complete clearance genital warts 8 week compare group .</detailed_description>
	<mesh_term>Warts</mesh_term>
	<mesh_term>Condylomata Acuminata</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<criteria>1 . Adults age 19 2 . Clinical diagnosis genital wart require treatment base clinician evaluation 3 . Fluency English 4 . Available within four day intend 8 week followup visit 1 . Individuals age 19 2 . Pregnant woman 3 . Known contraindication zinc Signs copper/iron deficiency include anemia neutropenia characterize tiredness , fatigue light headedness . 4 . Diseases alter zinc metabolism absorption eg . type II diabetes mellitus , Crohn 's disease , chronic leg ulcer 5 . Clients currently take zinc therapeutic purpose take zinc last two month therapeutic purpose 6 . Clients receive standard care treatment wart past month</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Warts</keyword>
	<keyword>HPV</keyword>
	<keyword>Zinc</keyword>
</DOC>